Congenital pseudarthrosis of the tibia

Last updated

Congenital Pseudarthrosis of the Tibia (CPT) is a rare paediatric disease presenting with a bowing deformity of the tibia at birth or within the first decade of life. [1] It is most commonly associated with Neurofibromatosis type 1 (NF-1). [2] For children with CPT, pathological fracture of the tibia eventually occurs, resulting in persistent nonunion of the fracture site. If left untreated, leg deformities, joint stiffness, leg-length discrepancy and pain will persist. [3] Diagnosis is done clinically and through X-ray imaging, with numerous classifications based on the severity of bowing and presence of fracture or intraosseous lesion. [4]

Contents

Pathogenesis of CPT remains unclear. Genetic factors may be related due to its association with NF-1, but does not completely explain the development and location of CPT. It is likely related to the involvement of pathological periosteum in the tibia, resulting in abnormal bone turnover. [1] [5]

Treatment for CPT is through surgical correction, to limit the progression of deformity and to correct shortening of the affected limb. Prognosis of treatment depends on site and type of CPT, and there is a risk of recurrent fracture. [6] [7]

About 1 in 150,000 births present with CPT, but aside from its association with NF-1, not much else is shown from epidemiological studies. [1] [4]

X-ray image of congenital pseudarthrosis of the tibia with anterior fracture TP NF.png
X-ray image of congenital pseudarthrosis of the tibia with anterior fracture

Signs and symptoms

Primary CPT presents at birth or in infants as anterolateral bowing of the tibia. Bowing is observed as shortening of the corresponding leg, and is confirmed with X-ray imaging. It is commonly presented unilaterally, but can be bilateral. [1] [8]

Secondary CPT does not present with obvious bowing at birth and may be overlooked, but will eventually progress to pathological fracture as the infant grows. Approximately 50% of fractures occur before the patient is two years of age, when toddlers begin learning to walk. [1] [8]

CPT is characterized by persistent nonunion because of fractures of the tibia and the presence of fibrous tissue between parts of the fractured bone. The persistent nonunion eventually leads to the formation of a false joint, otherwise known as pseudarthrosis. This pseudarthrosis is a non-healing bone lesion, resulting in reduction of mobility and persistent pain in the lower leg. [3]

Associated conditions

CPT is most commonly associated with NF-1, with around 50% of cases of CPT being developed from NF-1. [2] A complete neurological and dermatological examination should be done for a newborn baby with anterolateral bowing of the tibia to screen for NF-1. [9]

Diagnosis

Diagnosis is done through clinical examination and confirmed with radiographs of the tibia. Other associated clinical findings for NF-1, such as cafe-au-lait spots, neurofibromas and lisch nodules may also be found. [10] “Early onset” CPT is regarded as fracture occurring <4 years old, while “late onset” CPT is regarded as fracture occurring >4 years old. Numerous other classifications have been proposed for CPT, owing to the heterogeneity of the disease. [4] [11] The Crawford and Boyd classifications are more traditional descriptive classifications emphasizing the presence of sclerosis, cystic and atrophic changes of the tibia. The Paley classification is a more recent classification which also takes into account the fibula for treatment and outcome. [12]

Staging

Crawford classification [1] [13]
TypeFindings
IAnterior bowing with an increase in cortical density and a narrow medulla
IIAnterior bowing with narrow, sclerotic medulla
IIIAnterior bowing associated with a cyst or signs of a prefracture
IVAnterior bowing and a clear fracture with pseudarthrosis often associating the tibia and fibula
Boyd classification Type I - V Cropped Boyd classification I to V for pseudarthrosis of the tibia.png
Boyd classification Type I - V
Boyd classification [1] [14]
TypeFindings
IAnterior bowing associated with other congenital malformations
IIAnterior bowing with an hourglass appearance to the tibia. A fracture usually occurs before the age of 2. The ends of the bone are thin, rounded and sclerotic with obliteration of the intramedullary canal. This type is more often associated with NF-1 and there is a poor prognosis with frequent recurrence during bone growth
IIIPseudarthrosis developing from an intraosseous cyst, usually at the middle and distal third junction. Anterior bowing can precede or follow the development of the fracture. This type has a high rate of union and recurrence is rare
IVSclerotic bone with no pathological bowing. The medullary canal is partially or completely obliterated. A fatigue fracture may occur and progress to pseudarthrosis. The prognosis is good if treatment begins before the fatigue fracture occurs
VDysplastic appearance to the fibula. Pseudarthrosis can be located on either of the two bones of the tibial segment. The prognosis is good if the lesion is located only on the fibula, extension to the tibia has a prognosis similar to type II
VIAssociated with an intraosseous fibroma or a schwannoma. The prognosis depends on the aggressiveness of the intraosseous lesion
Paley classification [7]
TypeFindings
1No fractures
2ANo fracture of the tibia; fractured fibula, the fibula is not dislocated
2BNo fracture of the tibia; fractured and proximally migrated fibula
3Fractured tibia, no fracture of the fibula
4ATibia and fibula both fractured
4BTibia and fibula both fractured, the fibula is migrated proximally
4CBone defect of the tibia, the fibula is migrated proximally

Pathogenesis

The pathogenesis of CPT remains unclear nowadays. Various theories have been proposed in previous research, including mechanical, vascular, and genetic factors. However, none of these theories provide a comprehensive explanation for the development and location of CPT. [1]

Extensive research has highlighted the significant role of fibrous hamartoma and pathological periosteum in the development of CPT. [15] [16] [17] These factors are believed to hinder bone union by interposing mechanically and disrupt normal blood supply to the affected bone. The periosteum, in particular, may create a fibrous band that increases local pressure around the bone, leading to reduced vascularization and bone atrophy. [4] Additionally, thickening of blood vessel walls in the pseudarthrosis area may contribute to the vascularization defect. [18]

The association of NF-1 in a substantial portion (40 to 80%) of CPT cases suggests a potential genetic disorder. [19] Neurofibromin 1 (NF1) is a gene that codes for a protein called neurofibromin, which plays a crucial role in regulating the Ras protein—a key player in cell differentiation and proliferation. Neurofibromin normally acts as a tumor suppressor by converting Ras-GTP to an inactive form (Ras-GDP). [19] However, mutations in the NF1 gene result in the loss of neurofibromin function, leading to sustained activation of Ras. In certain CPT cases associated with NF-1, a double activation of the NF1 gene has been observed in the pseudarthrotic tissue. [20] This genetic abnormality which only presents in some cases, cannot solely explain the pathogenesis of CPT. The loss of neurofibromin function can lead to disturbances in the Ras-MAPK pathway, resulting in impaired osteoblastic differentiation. [21] Additionally, overexpression of the Ras pathway can increase the activity of osteoclasts and their precursors, contributing to bone resorption in CPT and the high incidence of recurrent fractures. [22] [23] In this case, the underlying pathogenic mechanisms of CPT likely involve a combination of signal abnormalities that enhance osteoclast activity, along with disturbances in osteoblastic differentiation, ultimately leading to defective bone remodeling. These processes are further exacerbated by the diminished local vascularization in the affected area. [1]

Treatment

Ilizarov Fixation

Ilizarov fixation is an effective surgical approach for treating CPT, particularly when significant bone gaps or deformities are present. The technique involves applying an external fixator framework known as an Ilizarov apparatus. Composed of rings connected by wires and thin wires or half-pins inserted into the bone, the apparatus allows precise control over bone alignment by gradually distracting or compressing bone ends. [24] Through application of regulated forces, the Ilizarov method stimulates new bone formation and facilitates bone union. Steady adjustments to the frame can progressively correct deformities, lengthen the bone, and induce consolidation across the pseudarthrosis site. [25] This technique has been proven to have high healing rate and a low refracture rate later on in clinical practice. [26] [25]

Sofield Fragmentation

The Sofield fragmentation technique entails making numerous small bone fractures via controlled osteotomies (surgical bone cuts) in the affected region. Orthopaedic surgeons then stabilize and compress the resultant bone fragments securely using internal fixation devices like plates, screws or intramedullary rods. By intentionally fracturing the bone in a regulated manner and ensuring stability, Sofield fragmentation promotes healing while also assisting consolidation at the pseudarthrosis site. [27] [24]

X-ray image of intramedullary nail for stabilization of the tibia Pseudarthrosis Tibia jmn.jpg
X-ray image of intramedullary nail for stabilization of the tibia

Intramedullary Stabilization

Intramedullary stabilization involves inserting a rod or nail into the tibial medullary canal. This offers structural support from within the affected bone, allowing for bone alignment and union. Surgeons may opt for flexible or rigid intramedullary nails depending on patient-specific factors such as age, pseudarthrosis severity and any accompanying deformities. [28] Although it almost guaranteed fracture healing and no refractures within a few years, the intramedullary nails would need to be replaced with age, leading to the pain of repeated surgery. [29] [30] [31]

Free Vascularized Fibular Grafts

In cases of extensive tibial bone loss or compromised blood flow, surgeons may perform a free vascularized fibular graft. This involves harvesting a section of fibula (usually 10–12 cm long) along with its blood supply from the patient's leg and transplanting it to the pseudarthrosis site. [32] As a vascularized graft, the fibula provides a fresh blood source to aid bone growth and repair at the defect location. [33] This unconventional procedure is reserved for the most challenging clinical presentations, saving many children with CPT from amputation since it was invented in the 1990s. [34] However, due to the lack of mechanical support, the healed bone has a high chance of refracture if this technique was applied alone for CPT treatment. [35] Therefore, it is commonly applied together with intramedullary nails in recent years so as to deal with both tibial loss and low bone mechanical strength, and has demonstrated satisfying efficacy in clinical practice. [36] [37]

Prognosis

In general, 75% of CPT treatments result in initial union, with an average initial union time of 7.2 months. 35% of cases will result in refracture after treatment. [6] [38] Prognosis of treatment depends on several factors relating to the nature and history of the fracture. Age of diagnosis is one of the factors as fractures in older patients are associated with better prognosis. This could be due to the greater cross-sectional bone area, allowing for lower refracture rates. [1] [6] Early diagnosis and surgical treatment before the disease progresses is also associated with favourable results and minimized deformity. [39] Site and type of pseudarthrosis have an impact on treatment success rate, as a lower location of fracture increases the complexity of the surgical operation due to the proximity with the ankle joint. More severe types of pseudarthrosis, such as those with severe bone deformities and significant leg length shortening is also associated with poor prognosis. [40] Patients with a history of multiple surgical interventions and recurrent fractures also indicate poor prognosis, and suggest a high risk of refracture after treatment. [1]

Epidemiology

CPT is a rare disease in children, with an estimated frequency of 1 in 150,000 births. [1] Few epidemiological studies for CPT have been done, so the racial and gender distribution is unknown. From its association with NF-1, it is found that around 50 percent of cases of CPT develop from NF-1, though recent studies found the percentage may be as high as 84%, due to CPT being diagnosed before other more subtle signs of NF-1 appear. [2] [19] In NF-1 cases, CPT occurs in infancy in approximately 5 percent of persons, with a male predominance of 1.7:1. [41]

Related Research Articles

<span class="mw-page-title-main">Ankle</span> Region where the foot and the leg meet

The ankle, the talocrural region or the jumping bone (informal) is the area where the foot and the leg meet. The ankle includes three joints: the ankle joint proper or talocrural joint, the subtalar joint, and the inferior tibiofibular joint. The movements produced at this joint are dorsiflexion and plantarflexion of the foot. In common usage, the term ankle refers exclusively to the ankle region. In medical terminology," can refer broadly to the region or specifically to the talocrural joint.

<span class="mw-page-title-main">Orthopedic surgery</span> Branch of surgery concerned with the musculoskeletal system

Orthopedic surgery or orthopedics is the branch of surgery concerned with conditions involving the musculoskeletal system. Orthopedic surgeons use both surgical and nonsurgical means to treat musculoskeletal trauma, spine diseases, sports injuries, degenerative diseases, infections, tumors, and congenital disorders.

An osteotomy is a surgical operation whereby a bone is cut to shorten or lengthen it or to change its alignment. It is sometimes performed to correct a hallux valgus, or to straighten a bone that has healed crookedly following a fracture. It is also used to correct a coxa vara, genu valgum, and genu varum. The operation is done under a general anaesthetic.

<span class="mw-page-title-main">Neurofibromatosis type I</span> Type of neurofibromatosis disease

Neurofibromatosis type I (NF-1), or von Recklinghausen syndrome, is a complex multi-system human disorder caused by the mutation of neurofibromin 1 (NF-1), a gene on chromosome 17 that is responsible for production of a protein (neurofibromin) which is needed for normal function in many human cell types. NF-1 causes tumors along the nervous system which can grow anywhere on the body. NF-1 is one of the most common genetic disorders and is not limited to any person's race or sex. NF-1 is an autosomal dominant disorder, which means that mutation or deletion of one copy of the NF-1 gene is sufficient for the development of NF-1, although presentation varies widely and is often different even between relatives affected by NF-1.

<span class="mw-page-title-main">Ilizarov apparatus</span> Type of external fixation (medical device)

In medicine, the Ilizarov apparatus is a type of external fixation apparatus used in orthopedic surgery to lengthen or to reshape the damaged bones of an arm or a leg; used as a limb-sparing technique for treating complex fractures and open bone fractures; and used to treat an infected non-union of bones, which cannot be surgically resolved. The Ilizarov apparatus corrects angular deformity in a leg, corrects differences in the lengths of the legs of the patient, and resolves osteopathic non-unions; further developments of the Ilizarov apparatus progressed to the development of the Taylor Spatial Frame.

<span class="mw-page-title-main">Malignant peripheral nerve sheath tumor</span> Medical condition

A malignant peripheral nerve sheath tumor (MPNST) is a form of cancer of the connective tissue surrounding nerves. Given its origin and behavior it is classified as a sarcoma. About half the cases are diagnosed in people with neurofibromatosis; the lifetime risk for an MPNST in patients with neurofibromatosis type 1 is 8–13%. MPNST with rhabdomyoblastomatous component are called malignant triton tumors.

<span class="mw-page-title-main">Nonunion</span> Failure of a bone to heal after breakage

Nonunion is permanent failure of healing following a broken bone unless intervention is performed. A fracture with nonunion generally forms a structural resemblance to a fibrous joint, and is therefore often called a "false joint" or pseudoarthrosis. The diagnosis is generally made when there is no healing between two sets of medical imaging, such as X-ray or CT scan. This is generally after 6–8 months.

<span class="mw-page-title-main">Neurofibromin 1</span> Mammalian protein found in humans

Neurofibromin 1 (NF1) is a gene in humans that is located on chromosome 17. NF1 codes for neurofibromin, a GTPase-activating protein that negatively regulates RAS/MAPK pathway activity by accelerating the hydrolysis of Ras-bound GTP. NF1 has a high mutation rate and mutations in NF1 can alter cellular growth control, and neural development, resulting in neurofibromatosis type 1. Symptoms of NF1 include disfiguring cutaneous neurofibromas (CNF), café au lait pigment spots, plexiform neurofibromas (PN), skeletal defects, optic nerve gliomas, life-threatening malignant peripheral nerve sheath tumors (MPNST), pheochromocytoma, attention deficits, learning deficits and other cognitive disabilities.

<span class="mw-page-title-main">Ollier disease</span> Medical condition

Ollier disease is a rare sporadic nonhereditary skeletal disorder in which typically benign cartilaginous tumors (enchondromas) develop near the growth plate cartilage. This is caused by cartilage rests that grow and reside within the metaphysis or diaphysis and eventually mineralize over time to form multiple enchondromas. Key signs of the disorder include asymmetry and shortening of the limb as well as an increased thickness of the bone margin. These symptoms are typically first visible during early childhood with the mean age of diagnosis being 13 years of age. Many patients with Ollier disease are prone to develop other malignancies including bone sarcomas that necessitate treatment and the removal of malignant bone neoplasm. Cases in patients with Ollier disease has shown a link to IDH1, IDH2, and PTH1R gene mutations. Currently, there are no forms of treatment for the underlying condition of Ollier disease but complications such as fractures, deformities, malignancies that arise from it can be treated through surgical procedures. The prevalence of this condition is estimated at around 1 in 100,000. It is unclear whether the men or women are more affected by this disorder due to conflicting case studies.

An open fracture, also called a compound fracture, is a type of bone fracture that has an open wound in the skin near the fractured bone. The skin wound is usually caused by the bone breaking through the surface of the skin. An open fracture can be life threatening or limb-threatening due to the risk of a deep infection and/or bleeding. Open fractures are often caused by high energy trauma such as road traffic accidents and are associated with a high degree of damage to the bone and nearby soft tissue. Other potential complications include nerve damage or impaired bone healing, including malunion or nonunion. The severity of open fractures can vary. For diagnosing and classifying open fractures, Gustilo-Anderson open fracture classification is the most commonly used method. This classification system can also be used to guide treatment, and to predict clinical outcomes. Advanced trauma life support is the first line of action in dealing with open fractures and to rule out other life-threatening condition in cases of trauma. The person is also administered antibiotics for at least 24 hours to reduce the risk of an infection.

<span class="mw-page-title-main">Gerdy's tubercle</span> Lateral tubercle of the tibia

Gerdy's tubercle is a lateral tubercle of the tibia, located where the iliotibial tract inserts. It was named after French surgeon Pierre Nicolas Gerdy (1797–1856).

<span class="mw-page-title-main">Taylor Spatial Frame</span>

The Taylor Spatial Frame (TSF) is an external fixator used by podiatric and orthopaedic surgeons to treat complex fractures and bone deformities. The medical device shares a number of components and features of the Ilizarov apparatus. The Taylor Spatial Frame is a hexapod device based on a Stewart platform, and was invented by orthopaedic surgeon Charles Taylor. The device consists of two or more aluminum or carbon fibre rings connected by six struts. Each strut can be independently lengthened or shortened to achieve the desired result, e.g. compression at the fracture site, lengthening, etc. Connected to a bone by tensioned wires or half pins, the attached bone can be manipulated in three dimensions and 9 degrees of freedom. Angular, translational, rotational, and length deformities can all be corrected simultaneously with the TSF.

<span class="mw-page-title-main">Fibular hemimelia</span> Congenital absence of the fibula

Fibular hemimelia or longitudinal fibular deficiency is "the congenital absence of the fibula and it is the most common congenital absence of long bone of the extremities." It is the shortening of the fibula at birth, or the complete lack thereof. Fibular hemimelia often causes severe knee instability due to deficiencies of the ligaments. Severe forms of fibula hemimelia can result in a malformed ankle with limited motion and stability. Fusion or absence of two or more toes are also common. In humans, the disorder can be noted by ultrasound in utero to prepare for amputation after birth or complex bone lengthening surgery. The amputation usually takes place at six months with removal of portions of the legs to prepare them for prosthetic use. The other treatments, which include repeated corrective osteotomies and leg-lengthening surgery, are costly and associated with residual deformity.

<span class="mw-page-title-main">Dror Paley</span> Canadian-trained orthopedic surgeon (born 1956)

Dror Paley is a Canadian-trained orthopedic surgeon, who specializes in limb lengthening and deformity correction procedures.

<span class="mw-page-title-main">Fracture blister</span> Medical condition in skin overlying a fractured bone

Fracture blisters occur on skin overlying a fractured bone, and fractures complicated by the development of overlying blisters remain a clinical dilemma in orthopedics.

<span class="mw-page-title-main">Crus fracture</span>

A crus fracture is a fracture of the lower legs bones meaning either or both of the tibia and fibula.

The following outline is provided as an overview of and topical guide to trauma and orthopaedics:

<span class="mw-page-title-main">Index of trauma and orthopaedics articles</span>

Orthopedic surgery is the branch of surgery concerned with conditions involving the musculoskeletal system. Orthopedic surgeons use both surgical and nonsurgical means to treat musculoskeletal injuries, sports injuries, degenerative diseases, infections, bone tumours, and congenital limb deformities. Trauma surgery and traumatology is a sub-specialty dealing with the operative management of fractures, major trauma and the multiply-injured patient.

<span class="mw-page-title-main">Tibia shaft fracture</span> Medical condition

Tibia shaft fracture is a fracture of the proximal (upper) third of the tibia. Due to the location of the tibia, it is frequently injured. Thus it is the most commonly fractured long bone in the body.

<span class="mw-page-title-main">David S. Feldman</span> Orthopedic Surgeon

David S. Feldman is an American orthopedic surgeon, author, contributor to NIH, and Associate Director of the Paley Orthopedic and Spine Institute. His work involves spinal deformities and complex conditions such as Arthrogryposis, skeletal dysplasia|, scoliosis, multiple hereditary exostoses, congenital pseudarthrosis of the tibia, hip dysplasia, and Legg–Calvé–Perthes disease as well as lower limb deformities and limb length discrepancies. He was previously Professor of Orthopedic Surgery and Pediatrics at NYU Langone Medical Center.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 Pannier S (November 2011). "Congenital pseudarthrosis of the tibia". Orthopaedics & Traumatology, Surgery & Research. 97 (7): 750–761. doi:10.1016/j.otsr.2011.09.001. PMID   21996526.
  2. 1 2 3 Van Royen K, Brems H, Legius E, Lammens J, Laumen A (September 2016). "Prevalence of neurofibromatosis type 1 in congenital pseudarthrosis of the tibia". European Journal of Pediatrics. 175 (9): 1193–1198. doi:10.1007/s00431-016-2757-z. PMID   27519821.
  3. 1 2 Agrawal U, Tiwari V (2024). "Congenital Tibial Pseudarthrosis". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID   35015468 . Retrieved 2024-04-10.
  4. 1 2 3 4 Hefti F, Bollini G, Dungl P, Fixsen J, Grill F, Ippolito E, et al. (January 2000). "Congenital pseudarthrosis of the tibia: history, etiology, classification, and epidemiologic data". Journal of Pediatric Orthopedics. Part B. 9 (1): 11–15. doi:10.1097/01202412-200001000-00003. PMID   10647103.
  5. ↑ "Congenital Pseudarthrosis of the Tibia (CPT) | Pediatric Orthopaedic Society of North America (POSNA)". posna.org. Retrieved 2024-04-10.
  6. 1 2 3 Kesireddy N, Kheireldin RK, Lu A, Cooper J, Liu J, Ebraheim NA (November 2018). "Current treatment of congenital pseudarthrosis of the tibia: a systematic review and meta-analysis". Journal of Pediatric Orthopedics. Part B. 27 (6): 541–550. doi:10.1097/BPB.0000000000000524. PMID   29878977.
  7. 1 2 Paley D (April 2019). "Congenital pseudarthrosis of the tibia: biological and biomechanical considerations to achieve union and prevent refracture". Journal of Children's Orthopaedics. 13 (2): 120–133. doi:10.1302/1863-2548.13.180147. PMC   6442511 . PMID   30996736.
  8. 1 2 Galois L, Girard D, Diligent J, Gasnier J, Bensoussan D, Mainard D (October 2004). "199 Résultats de la greffe de moelle osseuse dans les pseudarthroses et retards de consolidation de jambe : à propos de 20 observations". Revue de Chirurgie Orthopédique et Réparatrice de l'Appareil Moteur. 90 (6): 121. doi:10.1016/s0035-1040(04)70650-9. ISSN   0035-1040.
  9. ↑ Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, et al. (February 2007). "Guidelines for the diagnosis and management of individuals with neurofibromatosis 1". Journal of Medical Genetics. 44 (2): 81–88. doi:10.1136/jmg.2006.045906. PMC   2598063 . PMID   17105749.
  10. ↑ Ly KI, Blakeley JO (November 2019). "The Diagnosis and Management of Neurofibromatosis Type 1". The Medical Clinics of North America. 103 (6): 1035–1054. doi:10.1016/j.mcna.2019.07.004. PMID   31582003.
  11. ↑ "Disorders of the Leg", Tachdjian's Pediatric Orthopaedics, Elsevier, pp. 973–1033, 2008, doi:10.1016/b978-1-4160-2221-3.50026-8, ISBN   978-1-4160-2221-3
  12. ↑ Laufer A, Frommer A, Gosheger G, Roedl R, Schiedel F, Broeking JN, et al. (December 2020). "Reconstructive Approaches in Surgical Management of Congenital Pseudarthrosis of the Tibia". Journal of Clinical Medicine. 9 (12): 4132. doi: 10.3390/jcm9124132 . PMC   7767548 . PMID   33371504.
  13. ↑ Crawford AH, Bagamery N (January 1986). "Osseous manifestations of neurofibromatosis in childhood". Journal of Pediatric Orthopedics. 6 (1): 72–88. doi:10.1097/01241398-198601000-00015. PMID   3079778.
  14. ↑ Boyd HB (June 1982). "Pathology and Natural History of Congenital Pseudarthrosis of the Tibia". Clinical Orthopaedics and Related Research. 166: 5–13. doi:10.1097/00003086-198206000-00003. ISSN   0009-921X.
  15. ↑ Xie JH, Mei HB, Liu K, Zhu GH, Ouyang YQ, Huang Y, et al. (July 2022). "Analysis of related factors of behavioral problems in children with congenital pseudarthrosis of tibia". Revista da Associacao Medica Brasileira. 68 (7): 893–897. doi:10.1590/1806-9282.20211197. PMC   9574966 . PMID   35946764.
  16. ↑ Ari B, Kuyubasi SN (May 2021). "Bilateral congenital pseudarthrosis of the tibia with neurofibromatosis type 1". JPMA. The Journal of the Pakistan Medical Association. 71 (5): 1499–1502. doi: 10.47391/jpma.504 . PMID   34091645.
  17. ↑ Lee DY, Cho TJ, Lee HR, Lee K, Moon HJ, Park MS, et al. (September 2011). "Disturbed osteoblastic differentiation of fibrous hamartoma cell from congenital pseudarthrosis of the tibia associated with neurofibromatosis type I". Clinics in Orthopedic Surgery. 3 (3): 230–237. doi:10.4055/cios.2011.3.3.230. PMC   3162204 . PMID   21909471.
  18. ↑ "Review for "New insights of periosteum proteomics analysis on pathogenesis of congenital pseudarthrosis of tibia in children"". Rapid Communications in Mass Spectrometry. 2022-08-01. doi:10.1002/rcm.9374/v2/review1.
  19. 1 2 3 Crawford AH, Schorry EK (May 2006). "Neurofibromatosis update". Journal of Pediatric Orthopedics. 26 (3): 413–423. doi:10.1097/01.bpo.0000217719.10728.39. PMID   16670560.
  20. ↑ Chung E (December 2012). "Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)". Pediatric Imaging Cases. Oxford University Press. pp. 275–276. doi:10.1093/med/9780199758968.003.0131. ISBN   978-0-19-975896-8.
  21. ↑ Sakamoto A, Yoshida T, Yamamoto H, Oda Y, Tsuneyoshi M, Iwamoto Y (July 2007). "Congenital pseudarthrosis of the tibia: analysis of the histology and the NF1 gene". Journal of Orthopaedic Science. 12 (4): 361–365. doi:10.1007/s00776-007-1142-1. PMID   17657556.
  22. ↑ Leskelä HV, Kuorilehto T, Risteli J, Koivunen J, Nissinen M, Peltonen S, et al. (February 2009). "Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression". Bone. 44 (2): 243–250. doi:10.1016/j.bone.2008.10.050. PMID   19061981.
  23. ↑ Cho TJ, Seo JB, Lee HR, Yoo WJ, Chung CY, Choi IH (December 2008). "Biologic characteristics of fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1". The Journal of Bone and Joint Surgery. American Volume. 90 (12): 2735–2744. doi:10.2106/jbjs.h.00014. hdl: 10371/67451 . PMID   19047720.
  24. 1 2 Banchhor H, Chimurkar V (December 2022). "Congenital Pseudoarthrosis of the Tibia: A Narrative Review". Cureus. 14 (12): e32501. doi: 10.7759/cureus.32501 . PMC   9840411 . PMID   36654595.
  25. 1 2 Zhu GH, Mei HB, He RG, Liu YX, Liu K, Tang J, et al. (October 2016). "Combination of intramedullary rod, wrapping bone grafting and Ilizarov's fixator for the treatment of Crawford type IV congenital pseudarthrosis of the tibia: mid-term follow up of 56 cases". BMC Musculoskeletal Disorders. 17 (1): 443. doi: 10.1186/s12891-016-1295-1 . PMC   5075394 . PMID   27770774.
  26. ↑ Yalikun A, Yushan M, Hamiti Y, Lu C, Yusufu A (2022). "Combination of the Ilizarov Method and Intramedullary Fixation for the Treatment of Congenital Pseudarthrosis of the Tibia in Children: A Retrospective Observational Study". Frontiers in Surgery. 9: 901262. doi: 10.3389/fsurg.2022.901262 . PMC   9152179 . PMID   35656087.
  27. ↑ Sofield HA, Millar EA (December 1959). "Fragmentation, Realignment, and Intramedullary Rod Fixation of Deformities of the Long Bones in Children". The Journal of Bone & Joint Surgery. 41 (8): 1371–1391. doi:10.2106/00004623-195941080-00001. ISSN   0021-9355.
  28. ↑ Charnley J (April 1956). "Congenital Pseudarthrosis of the Tibia Treated by the Intramedullary Nail". The Journal of Bone & Joint Surgery. 38 (2): 283–290. doi:10.2106/00004623-195638020-00004. ISSN   0021-9355.
  29. ↑ Dobbs MB, Rich MM, Gordon JE, Szymanski DA, Schoenecker PL (June 2004). "Use of an intramedullary rod for treatment of congenital pseudarthrosis of the tibia. A long-term follow-up study". The Journal of Bone and Joint Surgery. American Volume. 86 (6): 1186–1197. doi:10.2106/00004623-200406000-00010. PMID   15173291.
  30. ↑ Shaw P (2012-07-30). "Recommendation of NIH Image to ImageJ: 25 years of image analysis". Faculty Opinions. doi: 10.3410/f.717968566.793456800 .
  31. ↑ Liu Y, Yang G, Zhu G, Tan Q, Wu J, Liu K, et al. (August 2021). "Application of the "telescopic rod" in a combined surgical technique for the treatment of congenital pseudarthrosis of the tibia in children". Journal of Orthopaedic Surgery and Research. 16 (1): 532. doi: 10.1186/s13018-021-02649-2 . PMC   8390273 . PMID   34446041.
  32. ↑ Weiland AJ, Weiss AP, Moore JR, Tolo VT (June 1990). "Vascularized fibular grafts in the treatment of congenital pseudarthrosis of the tibia". The Journal of Bone and Joint Surgery. American Volume. 72 (5): 654–662. doi:10.2106/00004623-199072050-00003. PMID   2355026.
  33. ↑ Dormans JP, Krajbich JI, Zuker R, Demuynk M (September–October 1990). "Congenital pseudarthrosis of the tibia: treatment with free vascularized fibular grafts". Journal of Pediatric Orthopedics. 10 (5): 623–628. doi:10.1097/01241398-199009000-00010. PMID   2394816.
  34. ↑ Hagan KF, Buncke HJ (June 1982). "Treatment of Congenital Pseudarthrosis of the Tibia with Free Vascularized Bone Graft". Clinical Orthopaedics and Related Research. 166: 34. doi:10.1097/00003086-198206000-00007. ISSN   0009-921X.
  35. ↑ Minami A, Ogino T, Sakuma T, Usui M (January 1987). "Free vascularized fibular grafts in the treatment of congenital pseudarthrosis of the tibia". Microsurgery. 8 (3): 111–116. doi:10.1002/micr.1920080302. PMID   3670033.
  36. ↑ Beris AE, Lykissas MG, Kostas-Agnantis I, Vasilakakos T, Vekris MD, Korompilias AV (March 2010). "Congenital pseudarthrosis of the radius treated with gradual distraction and free vascularized fibular graft: case report". The Journal of Hand Surgery. 35 (3): 406–411. doi:10.1016/j.jhsa.2009.11.022. PMID   20133088.
  37. ↑ El-Gammal TA, El-Sayed A, Kotb MM, Saleh WR, Ragheb YF, Refai OA, et al. (March 2021). "Crawford Type IV Congenital Pseudarthrosis of the Tibia: Treatment With Vascularized Fibular Grafting and Outcome at Skeletal Maturity". Journal of Pediatric Orthopedics. 41 (3): 164–170. doi:10.1097/BPO.0000000000001751. PMID   33448723.
  38. ↑ El-Gammal TA, Ali AE, Kotb MM, Saleh WR, Ragheb YF, Refai OA, et al. (July 2023). "Congenital Pseudarthrosis of the Tibia: Long-term Outcome of Treatment With Intramedullary Vascularized Fibular Graft Combined With Ilizarov Distraction". Journal of Pediatric Orthopedics. 43 (6): e487–e492. doi:10.1097/BPO.0000000000002399. PMID   36941117.
  39. ↑ Zargarbashi R, Bagherpour A, Keshavarz-Fathi M, Panjavi B, Bagherpour Zarchi M (August 2021). "Prognosis of Congenital Pseudarthrosis of the Tibia: Effect of Site of Tibial Pseudarthrososis and Fibular Involvement". Journal of Pediatric Orthopedics. 41 (7): 422–427. doi:10.1097/BPO.0000000000001861. PMID   34001806.
  40. ↑ Ohnishi I, Sato W, Matsuyama J, Yajima H, Haga N, Kamegaya M, et al. (March 2005). "Treatment of congenital pseudarthrosis of the tibia: a multicenter study in Japan". Journal of Pediatric Orthopedics. 25 (2): 219–224. doi:10.1097/01.bpo.0000151054.54732.0b. PMID   15718906.
  41. ↑ Stevenson DA, Birch PH, Friedman JM, Viskochil DH, Balestrazzi P, Boni S, et al. (June 1999). "Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1". American Journal of Medical Genetics. 84 (5): 413–419. doi:10.1002/(sici)1096-8628(19990611)84:5<413::aid-ajmg5>3.0.co;2-1. PMID   10360395.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.